Trial intelligence / Profile preview

KRX-0502 (Ferric Citrate) in NDD-CKD Anemia

NCT02128074Phase 2Completed

Sponsor
Keryx Biopharmaceuticals, Inc.
Start
Apr 2014
Primary completion
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ferric citrate in iron deficiency anemia (IDA), sponsored by Keryx Biopharmaceuticals, Inc.. Started Apr 2014; status: completed.

02

Drugs

ferric citrate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02128074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02128074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call